Therapeutic monoclonal antibodies that neuralize botulinum neurotoxins

Details for Australian Patent Application No. 2006332045 (hide)

International Classifications

Event Publications

16 August 2007 Application Open to Public Inspection

Published as AU-A-2006332045

16 August 2007 PCT application entered the National Phase

18 October 2007 Amendment Made

The nature of the amendment is: Amend the invention title to read Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

31 July 2008 Corrigenda

PCT applications Corrigenda that have entered the National Phase - Name Index Under the name The Regents of the University of California, Application No. 2006332045, under INID(43), correct the date to read 23.08.07

5 March 2009 Corrigenda

PCT applications that have entered the National Phase - Name Index Under the name The Regents of the University of California, Application No. 2006332045, under INID(43), correct the date to read 23.08.07

9 July 2009 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 03 Feb 2009

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.